POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 35 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $19,150,830 | +6.3% | 2,627,000 | +12.7% | 0.80% | +7.5% |
Q3 2022 | $18,018,000 | -12.2% | 2,330,902 | -22.7% | 0.75% | -4.2% |
Q2 2022 | $20,528,000 | -14.6% | 3,014,408 | 0.0% | 0.78% | +6.4% |
Q1 2022 | $24,025,000 | +60.5% | 3,014,408 | +12.8% | 0.73% | +153.1% |
Q4 2021 | $14,968,000 | -12.5% | 2,672,863 | +20.1% | 0.29% | +0.7% |
Q3 2021 | $17,110,000 | – | 2,225,000 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 2,312,523 | $18,431,000 | 4.36% |
GREAT POINT PARTNERS LLC | 2,060,000 | $16,418,000 | 3.97% |
RA Capital Management | 9,003,018 | $71,754,000 | 1.57% |
JOHNSON & JOHNSON | 1,000,000 | $7,970,000 | 1.51% |
BVF INC/IL | 3,367,826 | $26,842,000 | 1.07% |
Boxer Capital, LLC | 2,500,000 | $19,925,000 | 1.02% |
Sio Capital Management, LLC | 377,684 | $3,010,000 | 1.00% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $24,025,000 | 0.73% |
SILVERARC CAPITAL MANAGEMENT, LLC | 204,679 | $1,631,000 | 0.68% |
Atom Investors LP | 60,103 | $479,000 | 0.22% |